Stem cell-free therapy for healthy brain aging: Mechanisms, challenges, and prospects

Oct 23, 2025Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Stem Cell-Free Treatments for Healthy Brain Aging: How They Work, Challenges, and Future Possibilities

AI simplified

Regenerative Health on OpenScience ↗PubMed ↗DOI ↗

Abstract

The stem cell secretome, including extracellular vesicles (EVs), may have neuroprotective effects in brain aging.

Secretome constituents, particularly EVs, are associated with the regulation of pathways related to aging hallmarks.
EVs can cross the blood-brain barrier and deliver neuroprotective molecules to aged neural tissue.
The secretome may influence inflammation, apoptosis, mitochondrial damage, and cellular aging.
Restoration of neural homeostasis and induction of neurogenesis and angiogenesis could be facilitated by the secretome.
Acellular therapies based on secretome and EVs may present safer alternatives to traditional stem cell therapy.

AI simplified

The stem cell secretome, which includes bioactive molecules and extracellular vesicles (EVs), has been reported to have neuroprotective effects in various neurological conditions. Current research indicates that secretome constituents, particularly EVs, can regulate pathways related to aging hallmarks and are therapeutic targets for brain aging. EVs can traverse the blood-brain barrier (BBB) and transfer neuroprotective cargoes such as proteins, peptides, miRNAs, and lipids to aged neural tissue. By acting on inflammation, apoptosis, mitochondrial damage, and cellular senescence, the secretome can restore neural homeostasis and induce neurogenesis and angiogenesis. While stem cell therapy is hindered by the risk of tumorigenicity and immune rejection, secretome and EV-based acellular therapies are safer and possibly more targeted choices. The content and delivery optimization of such vesicles to influence significant regulatory pathways of aging is currently of interest. This review highlights the dual importance of mechanistic insights and translational perspectives and discusses our current understanding of how the secretome, along with EVs, regulates hallmarks of brain aging with practical aspects of clinical application. The present review provides a novel and comprehensive analysis of current knowledge on stem cell-derived secretome and EVs as targeted modulators for healthy brain aging, with a critical evaluation of translational hurdles and clinical implementation.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Stem cell-free therapy for healthy brain aging: Mechanisms, challenges, and prospects

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week: